Medicinova (MNOV) Shares Outstanding (2010 - 2025)
Medicinova's (MNOV) quarterly Shares Outstanding (Entity) came in at $49.2 million in Q4 2025, little changed year-on-year from $49.0 million in Q4 2024, and little changed on a QoQ basis from $49.0 million in Q3 2025.
Medicinova (MNOV) Shares Outstanding (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Shares Outstanding (Entity) data on file, last reported at $49.2 million in Q4 2025.
- On a quarterly basis, Shares Outstanding (Entity) changed 0.36% year-over-year to $49.2 million in Q4 2025; TTM through Dec 2025 was $49.2 million, a 0.36% change from a year earlier, with the FY2025 full-year figure at $49.2 million, changed 0.36% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $49.2 million, roughly flat from $49.0 million in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for MNOV reached as high as $49.2 million in Q4 2025 and fell as low as $48.8 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $49.0 million across 5 years, with a median of $49.0 million in 2022.
- Across the five-year window, Shares Outstanding (Entity) advanced 10.89% in 2021 and changed 0.0% in 2023, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $49.0 million in 2021, then grew by 0.01% to $49.0 million in 2022, then changed by 0.0% to $49.0 million in 2023, then changed by 0.0% to $49.0 million in 2024, then increased by 0.36% to $49.2 million in 2025.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $49.2 million in Q4 2025, $49.0 million in Q3 2025, and $49.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 47.82 Bn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.44 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 11.23 Bn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 62.19 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | 49.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.06 Mn |
| Sep 30, 2025 | 49.05 Mn |
| Jun 30, 2025 | 49.05 Mn |
| Mar 31, 2025 | 49.05 Mn |
| Dec 31, 2024 | 49.05 Mn |
| Sep 30, 2024 | 49.05 Mn |
| Jun 30, 2024 | 49.05 Mn |
| Mar 31, 2024 | 49.05 Mn |
| Dec 31, 2023 | 49.05 Mn |
| Sep 30, 2023 | 49.05 Mn |
| Jun 30, 2023 | 49.05 Mn |
| Mar 31, 2023 | 49.05 Mn |
| Dec 31, 2022 | 49.05 Mn |
| Sep 30, 2022 | 49.05 Mn |
| Jun 30, 2022 | 49.05 Mn |
| Mar 31, 2022 | 49.04 Mn |
| Dec 31, 2021 | 48.60 Mn |
| Sep 30, 2021 | 48.99 Mn |
| Jun 30, 2021 | 48.80 Mn |
| Mar 31, 2021 | 47.54 Mn |